KLI
STJ

Kelman-Lazarov Inc’s St Jude Medical STJ Stock Holding History

Kelman-Lazarov Inc’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-3,750
Closed -$207K – 395
2016
Q1 		$207K Buy
+3,750
New +$204K 0.12% 116

Other funds holding STJ

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Kelman-Lazarov Inc's STJ Position: Q2 2016 in Review

Kelman-Lazarov Inc sold out of St Jude Medical (STJ) in Q2 2016, closing a stake of 3,750 shares — an estimated $207K sold.

Kelman-Lazarov Inc first reported a position in STJ in Q1 2016 and held it in 1 quarter. The position peaked at $207K in Q1 2016. 615 funds tracked by Wall St. Rank hold STJ as of Q2 2016.

  • Kelman-Lazarov Inc reported no remaining St Jude Medical position as of Q2 2016 after selling out during the quarter.
  • Kelman-Lazarov Inc sold 3,750 St Jude Medical shares in Q2 2016, an estimated $207K.
  • Kelman-Lazarov Inc first reported a position in St Jude Medical in Q1 2016 and held it in 1 quarter.
  • Kelman-Lazarov Inc's St Jude Medical position peaked at $207K in Q1 2016.
  • 615 funds tracked by Wall St. Rank held St Jude Medical as of Q2 2016.

Based on Kelman-Lazarov Inc's 13F filing for Q2 2016, filed 14 Jul 2016.